Last update:
Inflammatory disorders news
Inflammatory disorders
Hydroxychloroquine safe, effective treatment for anogenital lichen sclerosus: Study
Hydroxychloroquine appears to be a safe and effective treatment option for anogenital lichen sclerosus that only has mild adverse effects, according to a study published online July 19 in the International Journal of Dermatology.
13 hours ago
0
0
Inflammatory disorders
Researchers highlight the limitations of a specific commercially available clinical genetic test in dermatology
Earlier this year, Department of Genetics professor Joel Sax, along with Christopher McFarland, assistant professor at the Department of Genetics and Genome Sciences, and Bryan Carroll, associate professor for the Department ...
13 hours ago
0
0
A drug that can extend your life by 25%? Don't hold your breath
Every few weeks or months, the media reports on a new study that tantalizingly dangles the possibility of a new drug to give us longer, healthier lives.
Jul 25, 2024
0
1
Newly identified immune cell switch could control inflammation
Cornell researchers have identified a switch that regulates inflammation caused by an immune response, a finding that could one day help clinicians control inflammation-related conditions such as autoimmune, cardiovascular ...
Jul 24, 2024
0
18
Positive causal association between rheumatoid arthritis, bronchiectasis
There is a causal association between genetically predicted rheumatoid arthritis (RA) and increased risk of bronchiectasis, according to a study published in Frontiers in Medicine.
Jul 24, 2024
0
4
Adverse event risk up for >90 days versus >30 days of corticosteroids for eczema
Use of oral corticosteroids for >90 days during one year is associated with a slightly increased risk of adverse events (AEs), according to a study published online July 19 in JAMA Network Open.
Jul 24, 2024
0
0
Air pollution exposure tied to new psoriasis
Long-term exposure to air pollution is associated with the development of new psoriasis, according to a study published online July 16 in JAMA Network Open.
Jul 18, 2024
0
0
Scientists discover switching off inflammatory protein leads to longer, healthier lifespans in mice
Scientists at the Medical Research Council Laboratory of Medical Science and Imperial College London have discovered that 'switching off' a protein called IL-11 can significantly increase the healthy lifespan of mice by almost ...
Jul 17, 2024
0
481
Direct calcitonin gene-related peptide inhibition found to reduce acne, rosacea in patients with migraine
For patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea compared with no inhibition (topiramate) ...
Jul 17, 2024
0
0
Race, ethnic disparities seen in age-adjusted prevalence of arthritis
The age-adjusted prevalence of arthritis varies by race and ethnicity, with higher prevalence seen among American Indian/Alaska Native adults, according to a study published in the July issue of Arthritis Care & Research.
Jul 17, 2024
0
25
Current asthma at age 7 linked to chronic rhinosinusitis in middle age
Current asthma, head colds, and tonsillitis at age 7 years are associated with chronic rhinosinusitis (CRS) at midlife, according to a study published online July 10 in Allergy.
Jul 16, 2024
0
0
Research suggests early life antibiotic increases asthma risk, providing clues to potential prevention of adult asthma
Early exposure to antibiotics can trigger long term susceptibility to asthma, according to new research from Monash University. Importantly, the research team isolated a molecule produced by gut bacteria that in the future ...
Jul 15, 2024
0
22
Scientists identify possible way to block muscle fatigue in long COVID, other diseases
Infections and neurodegenerative diseases cause inflammation in the brain. But for unknown reasons, patients with brain inflammation often develop muscle problems that seem to be independent of the central nervous system. ...
Jul 12, 2024
0
203
Q&A: Researchers discuss cellular inflammation uncovered in rare neurodegenerative condition
Researchers at The Hospital for Sick Children (SickKids) have found that inflammation in an immune cell may be responsible in part for some severe symptoms in a group of rare genetic conditions called lysosomal storage diseases ...
Jul 12, 2024
0
5
FDA approves Zoryve for atopic dermatitis
The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).
Jul 12, 2024
0
1
A novel cinnamaldehyde nanomedicine for rheumatoid arthritis treatment
A cross-institutional research team led by the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel cinnamaldehyde-based prodrug nanomedicine by utilizing cinnamaldehyde, a common food additive, ...
Jul 12, 2024
0
7
Omega-3 fatty acid intake may lessen acne severity
In a study in the Journal of Cosmetic Dermatology that included 60 individuals with mild to moderate acne, following the Mediterranean diet and taking omega-3 fatty acid supplements led to significant reductions in inflammatory ...
Jul 10, 2024
0
0
Osteoarthritis may double risk of speedy progression to severe multimorbidity, study finds
Osteoarthritis—a condition in which the protective cartilage on the ends of bones breaks down—may more than double the risk of speedy progression to accumulating severe long term conditions (multimorbidity), finds a 20 ...
Jul 9, 2024
0
41
Small molecules induce trained immunity, opening a new approach to fighting disease
Vaccines provide a front-line defense against dangerous viruses, training adaptive immune cells to identify and fight specific pathogens.
Jul 8, 2024
0
39
Ointment containing DNA molecules can combat allergic contact dermatitis
Researchers at the University of Bonn have isolated a DNA molecule that is suitable for combating allergic contact dermatitis in mice. The aptamer binds to certain immune system messenger substances, rendering them ineffective. ...
Jul 5, 2024
0
29
